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PREVENTION OFENDOTOXAEMIA IN OBSTRUCTIVE
JAUNDICE A COMPARATIVE STUDY
OF BILE SALTS
J.A. PAIN* and M.E. BAILEY
Department ofSurgery, Royal Surrey County Hospital, Guildford, Surrey, UK
Systemic endotoxaemia is associated with postoperative renal dysfunction in obstructive jaundice, and
can be prevented by the pre-operative administration of certain bile salts. In order to find the most
effective bile salt for use in this condition, a comparison of the anti-endotoxic activities of different bile
salts was performed. Bile salts were incubated in vitro with endotoxin and the resultant endotoxin level
was measured with a quantitative limulus assay. The in vivo effects of different oral bile salts on the
intestinal absorption of radiolabelled endotoxin from rats with obstructive jaundice were compared. The
in vitro and in vivo anti-endotoxic activities of bile salts related to their known detergent activities.
Deoxycholic acid and its conjugates were the most effective and should be the bile salts of choice for
further clinical evaluation in obstructive jaundice in man.
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INTRODUCTION
Postoperative acute renal failure occurs in9% of patients with obstructive jaundice1.
There is considerable evidence to implicate the presence of endotoxins within the
systemic circulation in the development of this renal dysfunction2-4. Systemic
endotoxaemia is believed to result from an increased absorption of intestinal
endotoxin into the portal circulation4’5 and its impaired removal by the Kupffer cells
within the liver6’7.
The presence of bile within the intestinal lumen reduces endotoxin absorption8’9.
Oral administration of bile salts abolishes endotoxaemia in rats with bile-duct
ligation4. In patients with obstructive jaundice, oral sodium deoxycholate prevents
both portal and systemic endotoxaemia and protects postoperative renal function1.
However, chenodeoxycholic acid is less effective in these roles1 and
ursodeoxycholic acid has been found to confer no benefit12. An in vitro and in vivo
comparison of bile salts has been performed to find which bile salt should be the most
effective anti-endotoxaemic agent for use in obstructive jaundice.
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METHODS
In Vitro Study
Different bile salts and their conjugates were compared as to their ability to inhibit
endotoxin activity in vitro. Bile salts were incubated with endotoxin and the resultant
endotoxin level was measured.
The bile salts (200 mg, >98% purity, Sigma) were dissolved in 99% ethanol (4 ml),
and then added to sodium phosphate buffer 86 ml, pH 7.0). Various concentration of
the bile-salt/buffer solution were mixed with Escherichia coli endotoxin (20
0111B4, Difco) in water (0.2 ml), made up to 2 ml with sodium phosphate buffer and
incubated at 37C for 6 h. The mixtures were then assayed for endotoxin by means of
a quantitative chromogenic limulus assay5. The assay had a lower limit of sensitivity
of lpg/ml endotoxin in water, with a coefficient of variation of 4% with 50pg/ml
endotoxin in water. All tests were performed in triplicate with appropriate controls.
In Vivo Study
Different bile salts and their conjugates were compared in their ability to prevent the
absorption of radiolabelled endotoxin from the intestines of rats with obstructive
jaundice.
Endotoxin was labelled with Cr51 according to the method of Braude et al. 13
Endotoxin, E.coli 0111B4 (700 mg, Sigma) was suspended in phosphate chloride
buffer (140 ml, pH 7). The endotoxin suspension was incubated at 37C for 24 h with
radiolabelled sodium chromate (300 MBq, Amersham International). After
incubation the endotoxin/sodium chromate was dialysed against de-ionized water,
weakly buffered with phosphate chloride, at room temperature, until there was no
longer any significant loss of radioactivity into the dialysate. The radiolabelled
endotoxin was stored at 4C in gas-evacuated vials and, prior to use, tested for
unbound chromium by further dialysis.
Seventy-four male Wistar rats (weight 270-300gm) underwent common bile-duct
(CBD) ligation and division or sham operation on Day 0 and were treated as shown
in Figure 1. The extrapancreatic part of the CBD was mobilized and divided between
silk ligatures, and in the sham operation a silk ligature was placed around the CBD
and then removed.
On Day 12, 63 rats (seven groups of nine) received one of the following bile salts in
an oral dose of6mg/100gm body weight every 8 h fortwo days: sodium deoxycholate,
cholic acid, chenodeoxycholic acid, ursodeoxycholic acid, sodium taurocholate,
sodium taurodeoxycholate, and glycodeoxycholic acid. A dose of 6mg bile salt/100
gm body weight was chosen since preliminary experiments had shown that this dose
of sodium deoxycholate had prevented the absorption of more than 60% of orally
administered radiolabelled endotoxin. On Day 14, 4 h after the final dose of bile
salts, radiolabelled endotoxin (2mg/100gm body weight) was given via a gavage tube
to all rats.
Four hours later the rats were killed by cervical dislocation, and immediate
laparotomy was performed. Ligatures were placed around the lower oesophagus and
distal rectum, and the intestines including the stomach were removed. The attached
mesentery was discarded and the intestines were counted for radioactivity to
calculate the percentage radioactivity remaining in the intestines. From three control
jaundiced rats the livers, lungs, spleens, kidneys, and samples of blood and uriec
were also measured for radioactivity.ENDOTOXAEMIA-WHICH BILE SALT? 23
NON-JAUNDICED JAUNDICED BILE SALT
CONTROLS CONTROLS TREATED
DAY 0 5 rats 6 rats 63 rats
Sham op. CBD ligation CBD ligation
12 days 12 days 12 days
2 days 2 days 2 days
starved of food starved of food starved of food
Oral bile salts
DAY 4 Radiolabelled Radiolabelled Radiolabelled
Endotoxin Endotoxin Endotoxin
Killed Killed Killed
4 hours later 4 hours later 4 hours later
Figure 1 Design of animal experiment.
Statistics
Comparisons between groups were made with.the Student’s t-test.
RESULTS
In Vitro Study
Controls in which only buffer was added to endotoxin showed no significant loss of
detectable endotoxin after incubation. All bile salts tested reduced the detectable
endotoxin level. The dihydroxy bile salts, glycodeoxycholic acid and deoxycholic
acid, proved to have the greatest in vitro anti-endotoxic action. Only 400txg/ml of
these bile salts was required to reduce the detectable endotoxin level from 10txg/ml to
<50pg/ml (20 000-fold decrease). The mean activities of other bile salts expressed as
a percentage of that of deoxycholic acid are shown in Table 1.
In Vivo Study
The rats each received 1.7ml radiolabelled endotoxin, which produced a mean 149
781 counts per minute. No diarrheogenic effect of the bile salts was evident. Two rats
in the chenodeoxycholic-acid-treated group and one in the taurocholate-treated
group died during the experiment and are not included in the results. In the sham-
operated (non-jaundiced) rats less than 10% (mean intestinal radioactivity count 137
079 +7373) of the radioactive label was absorbed, whereas in the jaundiced rats 65%
(mean intestinal radioactivity count 52 425 +_7193) was absorbed (t 19.2, d.f. 9,
P<0.001). The mean radioactivity counts per minute of the tissue and body fluids
taken from the three jaundiced control rats were liver 13 259, spleen 982, kidney
4873, urine 2240, packed cell blood 1871 per ml, plasma 724 per ml.
All bile salts tested, except ursodeoxyxholic acid, produced a significant (P<0.05)24 J.A. PAIN and M.E. BAILEY
Table 1 In vitro and in vivo comparison of bile salts. In vitro results expressed as bile-salt concentration
required to reduce the detectable endotoxin level from 101xg/ml to 50pg/ml. In vivo results expressed as
mean -+s.d. residual intestinal endotoxin radioactivity counts. In bracket: percentage activity compared to
glycodeoxycholic acid.
In Vitro In Vivo
Ixg/ml % 10 cpm
Secondary bile salts
Glycodeoxycholic acid 400 (100)
Deoxycholic acid 400 (100)
Na Glycodeoxycholate 500 (80)
Na Taurodeoxycholate 500 (80)
Chenodeoxycholic acid 600 (66)
Na Glycochenodeoxycholate 600 (66)
NaTaurochenodeoxycholate 700 (57)
Primary bile salts
Cholic acid 1700 (23)
Glychocolic acid 1700 (23)
Na Glycocholate <2000 (>20)
Na Taurocholate <2000 (>20)
Tertiary bile salts
Ursodeoxycholic acid <2000 (>20)
114 12 (100)
116 +- 18 (97)
106 _+23 (90)
105 -+ 16 (89)
89
84
7O
-+23 (79)
198 (74)
+-23 (62)
Student’s t-test ap>0.05
bp>0.01
cp>0.001
reduction in the absorption of the radiolabelled endotoxin. Glycodeoxycholic acid
was the most effective agent and reduced the percentage endotoxin absorption to a
mean 24 ---8. The activities of other bile salts expressed as a percentage of that of
glycodeoxycholic acid are shown in Table 1.
DISCUSSION
Bile salts are detergents and have a direct anti-endotoxic action in vitro, causing
inactivation of the endotoxin molecule14-16. Endotoxin, which is aggregated into
particles with a molecular weight of about 1 000 000, is disassociated by bile salts to
form non-toxic subunits with molecular weights of about 20 00014.
The presence of bile within the intestinal lumen prevents endotoxin absorption.
The clinical effects of endotoxaemia cannot be induced in healthy animals by the oral
administration of endotoxin even if doses 500-3000 times the minimal lethal
17 18 parenteral dose are given Endotoxin absorption is increased in obstructive
jaundice
4 or after bile-duct cannulation and external biliary drainage8, but is reduced
in obstructive jaundice if the endotoxin is incubated with a bile salt prior to its oral
administration19, if oral bile salts are administered4, or if internal biliary drainage is
performed9.
All bile salts tested had potent in vitro anti-endotoxic activities, and the most
active were those of the dihydroxy bile acid, deoxycholic acid and its conjugates, and
the least activity was shown by ursodeoxycholic acid. Lithocholic acid and its
conjugates were not tested since they are toxic and would be unsuitable for use inENDOTOXAEMIA-WHICH BILE SALT? 25
man. These results are consistent with previous studies examining the in vitro anti-
endotoxic activity of bile salts. Iwasaki and Tanikawa2 found that deoxycholic acid
was the most effective bile salt compared to chenodeoxycholic acid, its conjugates
and taurocholic acid. Liehr et al. 21, comparing conjugates of bile salts, showed that
those of deoxycholate had a greater anti-endotoxic activity than those of
chenodeoxycholate, while those of cholate were the least effective. These previous
studies measured endotoxic with a semiquantitative limulus assay based on a
subjective assessment of the type of gel formed. The assay used in the present
experiment was highly sensitive, reproducible and quantitative.
The comparative in vitro bile-salt activities related to their known critical micellar
concentration22’23, which supports the theory that it is the detergent properties of the
bile salts that render endotoxins inactive.
The labelling of endotoxin with Cr
51 was first described by Braude et al. 13 Although
there is uncertainty as to the exact location of the radiolabel within the endotoxin
molecule, the attachment is very stable both in vitro and in PiPo13’24-26. Four hours
after oral administration of the radiolabelled endotoxin to the jaundiced rats, some
absorbed radioactivity was in the liver, but most was present in the plasma. This
distribution is similar to that found after intravenous injection of Cr5x -labelled
endotoxin into animals13. Endotoxin binds to plasma high-density lipoproteins and
circulates in this complex form until cleared from the ciruclation27. In our study it is
unlikely that the Cr
51 present in the circulation was free, because if free Cr51 is
injected intravenously the majority can subsequently be found within the red-cell
28 29 layer and not within the plasma
There was increased absorption of radiolabelled endotoxin in the bile-duct-ligated
rat. This probably occurred due to a lack of intestinal bile rather than due to the
hyperbilirubinaemic state, since bile-duct cannulation in rats also leads to an
increased absorption of endotoxin8’9. All of the bile salts tested, except for
ursodeoxycholic acid, significantly reduced endotoxin absorption. As in the in vitro
study deoxycholic acid and its conjugates were the most effective, and the bile-salt
activities related to their known detergent activities2’21. A greater difference
between the bile-salt activities was shown by the in vitro test, but this probably
related to the bile salts being incubated with the endotoxin for 6 h in controlled
conditions, whereas in the in vivo test the endotoxin was given only 4 h before the
animal was killed; also, numerous biological variables could effect the interaction
of bile salts and endotoxin. The choice of the most suitable bile salt as a pro-
phylactic agent against endotoxaemia in obstructive jaundice depends not only
on the individual salt’s activity as determined in vitro but also on its metabolism and
action in vivo. It is probably unimportant whether a bile "acid" or bile "salt" is used,
since most bile "salts" precipitate as bile "acids" in the stomach as their precipitation
pH values are higher than the luminal pH3.
In order to prevent endotoxaemia in obstructive jaundice it is recommended that
deoxycholic acid or its conjugates be the agents of choice for further clinical
evaluation.
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